Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro

Akkermansia muciniphila is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of A. muciniphila to utilize human milk oligosac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2020-08, Vol.10 (1), p.14330-14330, Article 14330
Hauptverfasser: Kostopoulos, Ioannis, Elzinga, Janneke, Ottman, Noora, Klievink, Jay T., Blijenberg, Bernadet, Aalvink, Steven, Boeren, Sjef, Mank, Marko, Knol, Jan, de Vos, Willem M., Belzer, Clara
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14330
container_issue 1
container_start_page 14330
container_title Scientific reports
container_volume 10
creator Kostopoulos, Ioannis
Elzinga, Janneke
Ottman, Noora
Klievink, Jay T.
Blijenberg, Bernadet
Aalvink, Steven
Boeren, Sjef
Mank, Marko
Knol, Jan
de Vos, Willem M.
Belzer, Clara
description Akkermansia muciniphila is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of A. muciniphila to utilize human milk oligosaccharides. We found that A. muciniphila was able to grow on human milk and degrade HMOs. Analyses of the proteome of A. muciniphila indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α- l -fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows A. muciniphila to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of A. muciniphila to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health.
doi_str_mv 10.1038/s41598-020-71113-8
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7459334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2439624252</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</originalsourceid><addsrcrecordid>eNp1UU1r3DAQFSWlCWn-QA9BkEsuTq0vS74EQmibQqCX9ixkebxWVpY2kr2Qfx9tNw2bQuYyA-_Nm3k8hL6Q-orUTH3NnIhWVTWtK0kIYZX6gE5ozUVFGaVHB_MxOsv5oS4laMtJ-wkdM6oapVh7gsab9RrSZEJ2Bk-LdcFtRucNXjJkPC4FwZPzaxy9W8VsrB1Ncn3B5ojnMbktYBfKBBhM8k_YuwGwjaF3s4sh78Ctm1P8jD4Oxmc4e-mn6M_3b79v76r7Xz9-3t7cV1ZIORcvrGs6zhopRaO4BMNJD0JSIdjQDNwwatSgOOtVzzpJ6kEZBY3tpGHKcMpO0fVed7N0E_QWwpyM15vkJpOedDROv0WCG_UqbrXkomWMF4HLF4EUHxfIs55ctuC9CRCXrClnbUM5FbtbF_9RH-KSQrGniVKyIURyUlh0z7Ip5pxgeH2G1HqXpd5nqUuW-m-WWpWl80Mbryv_kisEtifkAoUVpIPb78s-A0CBq0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1887611741</pqid></control><display><type>article</type><title>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</title><source>MEDLINE</source><source>Nature Free</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature OA Free Journals</source><creator>Kostopoulos, Ioannis ; Elzinga, Janneke ; Ottman, Noora ; Klievink, Jay T. ; Blijenberg, Bernadet ; Aalvink, Steven ; Boeren, Sjef ; Mank, Marko ; Knol, Jan ; de Vos, Willem M. ; Belzer, Clara</creator><creatorcontrib>Kostopoulos, Ioannis ; Elzinga, Janneke ; Ottman, Noora ; Klievink, Jay T. ; Blijenberg, Bernadet ; Aalvink, Steven ; Boeren, Sjef ; Mank, Marko ; Knol, Jan ; de Vos, Willem M. ; Belzer, Clara</creatorcontrib><description>Akkermansia muciniphila is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of A. muciniphila to utilize human milk oligosaccharides. We found that A. muciniphila was able to grow on human milk and degrade HMOs. Analyses of the proteome of A. muciniphila indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α- l -fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows A. muciniphila to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of A. muciniphila to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-020-71113-8</identifier><identifier>PMID: 32868839</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/326 ; 631/326/2565/2134 ; 631/326/2565/855 ; Akkermansia - enzymology ; Akkermansia - growth &amp; development ; Fibroblast growth factor 2 ; Glycoside Hydrolases - metabolism ; Growth factors ; Humanities and Social Sciences ; Humans ; Milk ; Milk, Human - microbiology ; Mucus - metabolism ; multidisciplinary ; Oligosaccharides - metabolism ; Patients ; Periodontal diseases ; Periodontium ; Platelet-derived growth factor ; Platelet-derived growth factor BB ; Probiotics ; Regeneration ; Science ; Science (multidisciplinary) ; Systematic review ; Therapeutic applications</subject><ispartof>Scientific reports, 2020-08, Vol.10 (1), p.14330-14330, Article 14330</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</citedby><cites>FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459334/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459334/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32868839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kostopoulos, Ioannis</creatorcontrib><creatorcontrib>Elzinga, Janneke</creatorcontrib><creatorcontrib>Ottman, Noora</creatorcontrib><creatorcontrib>Klievink, Jay T.</creatorcontrib><creatorcontrib>Blijenberg, Bernadet</creatorcontrib><creatorcontrib>Aalvink, Steven</creatorcontrib><creatorcontrib>Boeren, Sjef</creatorcontrib><creatorcontrib>Mank, Marko</creatorcontrib><creatorcontrib>Knol, Jan</creatorcontrib><creatorcontrib>de Vos, Willem M.</creatorcontrib><creatorcontrib>Belzer, Clara</creatorcontrib><title>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Akkermansia muciniphila is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of A. muciniphila to utilize human milk oligosaccharides. We found that A. muciniphila was able to grow on human milk and degrade HMOs. Analyses of the proteome of A. muciniphila indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α- l -fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows A. muciniphila to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of A. muciniphila to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health.</description><subject>631/326</subject><subject>631/326/2565/2134</subject><subject>631/326/2565/855</subject><subject>Akkermansia - enzymology</subject><subject>Akkermansia - growth &amp; development</subject><subject>Fibroblast growth factor 2</subject><subject>Glycoside Hydrolases - metabolism</subject><subject>Growth factors</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Milk</subject><subject>Milk, Human - microbiology</subject><subject>Mucus - metabolism</subject><subject>multidisciplinary</subject><subject>Oligosaccharides - metabolism</subject><subject>Patients</subject><subject>Periodontal diseases</subject><subject>Periodontium</subject><subject>Platelet-derived growth factor</subject><subject>Platelet-derived growth factor BB</subject><subject>Probiotics</subject><subject>Regeneration</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Systematic review</subject><subject>Therapeutic applications</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1UU1r3DAQFSWlCWn-QA9BkEsuTq0vS74EQmibQqCX9ixkebxWVpY2kr2Qfx9tNw2bQuYyA-_Nm3k8hL6Q-orUTH3NnIhWVTWtK0kIYZX6gE5ozUVFGaVHB_MxOsv5oS4laMtJ-wkdM6oapVh7gsab9RrSZEJ2Bk-LdcFtRucNXjJkPC4FwZPzaxy9W8VsrB1Ncn3B5ojnMbktYBfKBBhM8k_YuwGwjaF3s4sh78Ctm1P8jD4Oxmc4e-mn6M_3b79v76r7Xz9-3t7cV1ZIORcvrGs6zhopRaO4BMNJD0JSIdjQDNwwatSgOOtVzzpJ6kEZBY3tpGHKcMpO0fVed7N0E_QWwpyM15vkJpOedDROv0WCG_UqbrXkomWMF4HLF4EUHxfIs55ctuC9CRCXrClnbUM5FbtbF_9RH-KSQrGniVKyIURyUlh0z7Ip5pxgeH2G1HqXpd5nqUuW-m-WWpWl80Mbryv_kisEtifkAoUVpIPb78s-A0CBq0A</recordid><startdate>20200831</startdate><enddate>20200831</enddate><creator>Kostopoulos, Ioannis</creator><creator>Elzinga, Janneke</creator><creator>Ottman, Noora</creator><creator>Klievink, Jay T.</creator><creator>Blijenberg, Bernadet</creator><creator>Aalvink, Steven</creator><creator>Boeren, Sjef</creator><creator>Mank, Marko</creator><creator>Knol, Jan</creator><creator>de Vos, Willem M.</creator><creator>Belzer, Clara</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200831</creationdate><title>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</title><author>Kostopoulos, Ioannis ; Elzinga, Janneke ; Ottman, Noora ; Klievink, Jay T. ; Blijenberg, Bernadet ; Aalvink, Steven ; Boeren, Sjef ; Mank, Marko ; Knol, Jan ; de Vos, Willem M. ; Belzer, Clara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/326</topic><topic>631/326/2565/2134</topic><topic>631/326/2565/855</topic><topic>Akkermansia - enzymology</topic><topic>Akkermansia - growth &amp; development</topic><topic>Fibroblast growth factor 2</topic><topic>Glycoside Hydrolases - metabolism</topic><topic>Growth factors</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Milk</topic><topic>Milk, Human - microbiology</topic><topic>Mucus - metabolism</topic><topic>multidisciplinary</topic><topic>Oligosaccharides - metabolism</topic><topic>Patients</topic><topic>Periodontal diseases</topic><topic>Periodontium</topic><topic>Platelet-derived growth factor</topic><topic>Platelet-derived growth factor BB</topic><topic>Probiotics</topic><topic>Regeneration</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Systematic review</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kostopoulos, Ioannis</creatorcontrib><creatorcontrib>Elzinga, Janneke</creatorcontrib><creatorcontrib>Ottman, Noora</creatorcontrib><creatorcontrib>Klievink, Jay T.</creatorcontrib><creatorcontrib>Blijenberg, Bernadet</creatorcontrib><creatorcontrib>Aalvink, Steven</creatorcontrib><creatorcontrib>Boeren, Sjef</creatorcontrib><creatorcontrib>Mank, Marko</creatorcontrib><creatorcontrib>Knol, Jan</creatorcontrib><creatorcontrib>de Vos, Willem M.</creatorcontrib><creatorcontrib>Belzer, Clara</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kostopoulos, Ioannis</au><au>Elzinga, Janneke</au><au>Ottman, Noora</au><au>Klievink, Jay T.</au><au>Blijenberg, Bernadet</au><au>Aalvink, Steven</au><au>Boeren, Sjef</au><au>Mank, Marko</au><au>Knol, Jan</au><au>de Vos, Willem M.</au><au>Belzer, Clara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2020-08-31</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>14330</spage><epage>14330</epage><pages>14330-14330</pages><artnum>14330</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Akkermansia muciniphila is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of A. muciniphila to utilize human milk oligosaccharides. We found that A. muciniphila was able to grow on human milk and degrade HMOs. Analyses of the proteome of A. muciniphila indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α- l -fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows A. muciniphila to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of A. muciniphila to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32868839</pmid><doi>10.1038/s41598-020-71113-8</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2020-08, Vol.10 (1), p.14330-14330, Article 14330
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7459334
source MEDLINE; Nature Free; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; Springer Nature OA Free Journals
subjects 631/326
631/326/2565/2134
631/326/2565/855
Akkermansia - enzymology
Akkermansia - growth & development
Fibroblast growth factor 2
Glycoside Hydrolases - metabolism
Growth factors
Humanities and Social Sciences
Humans
Milk
Milk, Human - microbiology
Mucus - metabolism
multidisciplinary
Oligosaccharides - metabolism
Patients
Periodontal diseases
Periodontium
Platelet-derived growth factor
Platelet-derived growth factor BB
Probiotics
Regeneration
Science
Science (multidisciplinary)
Systematic review
Therapeutic applications
title Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T16%3A32%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Akkermansia%20muciniphila%20uses%20human%20milk%20oligosaccharides%20to%20thrive%20in%20the%20early%20life%20conditions%20in%20vitro&rft.jtitle=Scientific%20reports&rft.au=Kostopoulos,%20Ioannis&rft.date=2020-08-31&rft.volume=10&rft.issue=1&rft.spage=14330&rft.epage=14330&rft.pages=14330-14330&rft.artnum=14330&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-020-71113-8&rft_dat=%3Cproquest_pubme%3E2439624252%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1887611741&rft_id=info:pmid/32868839&rfr_iscdi=true